Zafgen (NASDAQ: ZFGN) is on watch after shares were halted ahead of a news release made early Wednesday afternoon.In the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk Trading Halts

Cowen Cuts Price Target on Zafgen (ZFGN) as Beloranib is Placed on Hold Following Patient Death October 16, 2015 1:28 PM Zafgen (ZFGN) PT Lowered to $46 at RBC Capital; Discusses Road Ahead for BeloranibOctober 15, 2015 7:17 AM Zafgen (ZFGN) PT Cut to $48 at FBR Capital on Patient DeathOctober 15, 2015 6:39 AM Leerink Partners Comments on Zafgen (ZFGN) Following Patient DeathOctober 14, 2015 2:26 PM Zafgen (ZFGN) Stock Expected to Languish Until More is Known - CowenOctober 14, 2015 2:20 PM Zafgen (ZFGN) Worst Case Scenario Avoided, RBC Capital - BloombergOctober 14, 2015 1:18 PM Zafgen (ZFGN) triggers limit-up, limit-down trading pauseOctober 14, 2015 12:31 PM Zafgen (ZFGN) Issues Statement; FDA Initiates Discussion Following Phase 3 bestPWS DeathOctober 14, 2015 12:01 PM